Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04568980 · ClinicalTrials.gov registry record
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 562
- Enrollment target
NCT04568980 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 562 participants.
The verdict
NCT04568980 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 562 participants
- Enrollment target
Study Summary
The long-term goal is to study the safety and effectiveness of hormonal contraception for women with cystic fibrosis (CF) and contribute to national guidelines that the Cystic Fibrosis Foundation and the Centers for Disease Control and Prevention (CDC) provide to clinicians. The study objectives are to determine whether hormonal contraceptive methods improve overall pulmonary health, worsen CF-related disease or CF liver disease, or are effective against unwanted pregnancy with concomitant CF transmembrane conductance regulator (CFTR) modulator use. The hypothesis is that hormonal contraceptive methods are safe and do not worsen CF-related complications over time,improve FEV-1 when compared to non-hormonal users, and oral birth control methods with CFTR modulator use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 562 participants |
| Start Date | 2020-09-30 |
| Est. Completion | 2022-12-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04568980
The ClinicalTrials.gov registry entry for NCT04568980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 562 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04568980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04568980 about?
NCT04568980 is a clinical study titled "Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis". The long-term goal is to study the safety and effectiveness of hormonal contraception for women with cystic fibrosis (CF) and contribute to national guidelines that the Cystic Fibrosis Foundation and the Centers for Disease Control and Prevention (CDC) provide to clinicians. The study objectives are...
What is the current status of trial NCT04568980?
This trial is currently completed. The enrollment target is 562 participants. The study started on 2020-09-30. Estimated completion is 2022-12-06.
Who is sponsoring clinical trial NCT04568980?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.